| Fund ID | 805-2453860275 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | No |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 0% |
| Owned by funds of funds | 2% |
| Owned by non-U.S. persons | 85% |
| Fund | Type | Gross assets |
|---|---|---|
| Ares Senior Credit Master Fund III LP | Hedge | $17.94B |
| Ares Senior Direct Lending Master Fund II Designated Activity Company | Hedge | $12.92B |
| Ares European Credit Strategies Fund IX (c), L.P. | Hedge | $11.72B |
Pharmatech Holdings II Ltd reports $108.9 million in gross assets, among the top 41% of private funds by size.
The stated minimum investment is $100,000.
Pharmatech Holdings II Ltd is managed by Ares Management LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.